New Drug Combo Reverses Treatment-Resistant Prostate Cancer Identity Switch
Researchers have discovered a potential strategy to combat treatment-resistant prostate cancer by combining two existing drug classes—BET bromodomain inhibitors and DNMT inhibitors—to reverse lineage plasticity, a process where cancer cells ... Read More